Analyst Ratings for Day One Biopharmaceuticals (DAWN)
DAWN Rating Summary
DAWN Price Target Summary
- Highest: $21.50 (JPMorgan)
- Lowest: $21.50 (JPMorgan)
- Average: $21.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$21.50 (-0.1%)
* Over Last 12-Mos
Rating Score: 2.7 / 10
Percentile Rank: 22%
Avg. $ Target:
$21.50 (-0.1%)
* Over Last 12-Mos
Rating Score: 2.7 / 10
Percentile Rank: 22%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Hold (N/A) |
21.50 (N/A) |
21.45 (21.53) |
0.37% | Details |
| 3/11/2026 | JPMorgan | Anupam Rama | Downgrade | Neutral (Overweight) |
21.50 (27.00) |
21.33 (21.53) |
0.94% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
